Home/Filings/4/0001181431-12-025889
4//SEC Filing

MAULDIN JOHN F 4

Accession 0001181431-12-025889

CIK 0001133416other

Filed

Apr 25, 8:00 PM ET

Accepted

Apr 26, 6:23 PM ET

Size

7.6 KB

Accession

0001181431-12-025889

Insider Transaction Report

Form 4
Period: 2012-04-24
Transactions
  • Purchase

    Common Stock

    2012-04-25$3.08/sh+1,100$3,3884,947 total(indirect: By Trust)
  • Purchase

    Common Stock

    2012-04-24$2.94/sh+3,847$11,3103,847 total(indirect: By Trust)
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.94 to $2.97 inclusive. The reporting person undertakes to provide Galectin Therapeutics Inc., any security holder of Galectin Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.97 to $3.08 inclusive. The reporting person undertakes to provide Galectin Therapeutics Inc., any security holder of Galectin Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  • [F3]On the transaction date stated in column 2 of this row in Table I, the reporting person contributed the shares stated in column 4 of such row to a retirement fund trust of which the reporting person is a trustee and a beneficiary. The reporting person continues to report ownership of all Galectin Therapeutics common stock held by the trust but disclaims beneficial ownership except to the extent of his pecuniary interest therein.

Issuer

GALECTIN THERAPEUTICS INC

CIK 0001133416

Entity typeother

Related Parties

1
  • filerCIK 0001522480

Filing Metadata

Form type
4
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 6:23 PM ET
Size
7.6 KB